Examkin

Question

Difficulty: MediumResearch Ethics and Conflicts of Interest

An institutional Conflict of Interest (COI) Committee is evaluating a Principal Investigator's newly declared financial relationship with a biotechnology startup. The startup manufactures a novel surgical device that the investigator plans to evaluate in an upcoming federally funded clinical trial. To protect the integrity of the research and ensure patient safety, the committee must implement a progressive management plan. Arrange the following potential conflict of interest management strategies in sequential order from the LEAST restrictive (baseline transparency) to the MOST restrictive (severe mitigation).

  1. 1Require full disclosure of the financial interest to research participants during the consent process and in all subsequent academic publications.
  2. 2Appoint an independent, non-conflicted third-party data monitoring committee to audit the trial data.
  3. 3Prohibit the investigator from participating in critical, bias-sensitive study procedures, such as subject enrollment and primary data analysis.
  4. 4Mandate complete divestiture of the financial interest or require the investigator to step down from the study entirely.

Answer

The correct order from least to most restrictive is: require full disclosure, appoint an independent data monitoring committee, prohibit participation in bias-sensitive procedures, and finally, mandate complete divestiture or resignation.
The management of financial conflicts of interest (COI) in clinical research follows a hierarchical approach based on the severity of the conflict and the risk of bias. The least restrictive approach relies entirely on transparency (full disclosure to subjects, IRBs, and journals). As the risk of bias increases, institutions apply progressively stricter measures: first adding independent oversight (such as a data monitoring committee), then actively restricting the investigator from bias-sensitive activities (like obtaining informed consent or performing primary data analysis), and finally, in the most severe cases where the conflict cannot be otherwise managed, mandating complete divestiture of the financial interest or the removal of the investigator from the study.

Step-by-Step Solution

1
Identify the baseline requirement for managing all financial conflicts of interest.
Select full disclosure to participants and journals.
Transparency is the minimum ethical standard and the least restrictive action, as it informs others without changing how the study is conducted.
2
Identify the next level of intervention that adds oversight without removing the investigator's clinical or research duties.
Select the appointment of an independent third-party monitoring committee.
This strategy adds a layer of protection against bias through auditing, but allows the investigator to continue their normal study activities unrestricted.
3
Identify the strategy that actively limits the investigator's participation in the trial.
Select prohibiting the investigator from participating in sensitive procedures (e.g., consent, data analysis).
This is highly restrictive as it fundamentally alters the Principal Investigator's role, stripping them of core duties where bias could most easily influence outcomes.
4
Identify the ultimate, most severe mitigation strategy.
Select complete divestiture of financial interests or stepping down from the trial.
Complete severance of the financial tie or the research role is the absolute most restrictive action possible, utilized when a conflict is deemed unmanageable by any lesser means.

Key Concept

Management strategies for financial conflicts of interest in research

Alternative Method

When evaluating COI management, categorizing the strategies by their direct impact on the investigator's daily actions (No impact -> Oversight -> Restricted actions -> Removal) naturally yields the correct least-to-most restrictive sequence.
Estimated Time:1m 30s
Rate this question

Topics

Research Ethics and Conflicts of Interest

More questions from this topic